Subthalamic Nucleus Stimulation With Directional Leads on Patients With Parkinson Disease at Fluctuations and Dyskinesia Stage
NCT ID: NCT05103072
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
13 participants
OBSERVATIONAL
2021-09-21
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators used to chose the best plot of the leads for stimulation by a procedure long and exhausting for the patient and the examinator.
The investigators can chose the plot using a software (Guide Xt), which can delete the exhausting test.
The investigators would like to study the non inferiority of this tool to choose the best plot .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information
NCT01537224
Sub-thalamic Nucleus Stimulation in Parkinson Disease
NCT01817088
Local Fields Potentientals of the Subthalamic Nucleus in Patients With Parkinson's Disease
NCT05820425
Combined Deep Brain Stimulation in Parkinson's Disease
NCT05415774
Subthalamic Nucleus Stimulation Effect on Gait Symmetry and Freezing of Gait
NCT02704195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
testing all the plots
the investigator chose the best plot of the leads for stimulation by a procedure long and exhausting for the patient and the examinator (" plot by plot ")
No interventions assigned to this group
Guide X Software
the investigator can chose the plot using a software (Guide Xt), which can delete the exhausting test
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patient with Parkinson disease eligible for sub thalamic surgery (CAPSIT criterias) in CHU AMIENS
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire, Amiens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens Picardie
Amiens, Picardie, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Aubignat M, Berro A, Tir M, Lefranc M. Imaging-Guided Subthalamic Nucleus Deep Brain Stimulation Programming for Parkinson Disease: A Real-Life Pilot Study. Neurol Clin Pract. 2024 Dec;14(6):e200326. doi: 10.1212/CPJ.0000000000200326. Epub 2024 Sep 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2021_843_0162
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.